Growing community of inventors

Boulder, CO, United States of America

Samuel Kintz

Average Co-Inventor Count = 3.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Samuel KintzJoseph P Lyssikatos (4 patents)Samuel KintzLi Ren (4 patents)Samuel KintzLewis J Gazzard (1 patent)Samuel KintzJoy Drobnick (1 patent)Samuel KintzCharles Ellwood (1 patent)Samuel KintzQiang Su (1 patent)Samuel KintzCalum Macleod (1 patent)Samuel KintzKaren Williams (1 patent)Samuel KintzSimon Goodacre (1 patent)Samuel KintzHazel Joan Dyke (1 patent)Samuel KintzHuifen Chen (1 patent)Samuel KintzSamuel Kintz (4 patents)Joseph P LyssikatosJoseph P Lyssikatos (139 patents)Li RenLi Ren (40 patents)Lewis J GazzardLewis J Gazzard (6 patents)Joy DrobnickJoy Drobnick (1 patent)Charles EllwoodCharles Ellwood (1 patent)Qiang SuQiang Su (1 patent)Calum MacleodCalum Macleod (11 patents)Karen WilliamsKaren Williams (7 patents)Simon GoodacreSimon Goodacre (3 patents)Hazel Joan DykeHazel Joan Dyke (3 patents)Huifen ChenHuifen Chen (11 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Enliven, Inc. (3 from 4 patents)

2. Enliven Therapeutics, Inc. (1 from 1 patent)


4 patents:

1. 12240846 - 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

2. 11807638 - 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

3. 11807649 - Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2

4. 11767321 - 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…